Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001102624-13-001389
Filing Date
2013-11-13
Accepted
2013-11-13 16:02:03
Documents
16
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 BOSTON THERAPEUTICS, INC. 10-Q boston10q.htm 10-Q 506580
2 EXHIBIT 4.1 exh4_1.htm EX-4.1 110098
3 EXHIBIT 4.2 exh4_2.htm EX-4.2 105240
4 EXHIBIT 10.1 exh10_1.htm EX-10.1 215075
5 EXHIBIT 10.2 exh10_2.htm EX-10.2 335622
6 EXHIBIT 10.3 exh10_3.htm EX-10.3 139341
7 EXHIBIT 31.1 exh31_1.htm EX-31.1 18486
8 EXHIBIT 31.2 exh31_2.htm EX-31.2 18090
9 EXHIBIT 32.1 exh32_1.htm EX-32.1 6845
10 EXHIBIT 32.2 exh32_2.htm EX-32.2 6990
  Complete submission text file 0001102624-13-001389.txt   3675209

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT bthe-20130930.xml EX-101.INS 362090
12 XBRL TAXONOMY EXTENSION SCHEMA bthe-20130930.xsd EX-101.SCH 24153
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bthe-20130930_cal.xml EX-101.CAL 29047
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bthe-20130930_def.xml EX-101.DEF 25439
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE bthe-20130930_lab.xml EX-101.LAB 168802
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bthe-20130930_pre.xml EX-101.PRE 111828
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54586 | Film No.: 131214584
SIC: 2834 Pharmaceutical Preparations